Flexion Therapeutics to Present at the 41st Annual Raymond James Institutional Investors Conference
February 24 2020 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it
will be presenting at the 41st Annual Raymond James
Institutional Investors Conference in Orlando,
Florida. Michael Clayman, M.D., President and Chief Executive
Officer, is scheduled to present at 11:35 a.m.
ET on Monday, March 2, 2020.
To access the live webcast and subsequent archived recording of
the presentation, please visit the Flexion website
at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics Flexion Therapeutics
(Nasdaq:FLXN) is a biopharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of people with musculoskeletal conditions, beginning with
osteoarthritis, the most common form of arthritis. The Company's
core values are focus, ingenuity, tenacity, transparency and fun.
Visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Sep 2023 to Sep 2024
